Get the Stockscreener App
1.62
8.00%
0.12
Pre-market:
1.61
-0.01
-0.62%
Maxcyte Inc stock is traded at $1.62, with a volume of 593.91K.
It is up +8.00% in the last 24 hours and up +15.71% over the past month.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
See More
Previous Close:
$1.50
Open:
$1.5
24h Volume:
593.91K
Relative Volume:
0.78
Market Cap:
$172.70M
Revenue:
$45.44M
Net Income/Loss:
$-35.43M
P/E Ratio:
-4.7647
EPS:
-0.34
Net Cash Flow:
$-25.39M
1W Performance:
+9.46%
1M Performance:
+15.71%
6M Performance:
-49.22%
1Y Performance:
-60.10%
1-Day Range:
$1.50
$1.63
1-Week Range:
$1.415
$1.63
52-Week Range:
$1.26
$5.20
Maxcyte Inc Stock (MXCT) Company Profile
Name
Maxcyte Inc
Sector
Industry
Phone
301-517-5556
Address
9713 KEY WEST AVENUE,, ROCKVILLE
Compare MXCT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
1.62 | 159.91M | 45.44M | -35.43M | -25.39M | -0.34 |
|
ABT
Abbott Laboratories
|
134.57 | 233.52B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
98.23 | 145.95B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
377.84 | 144.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.59 | 121.32B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.55 | 44.15B | 5.69B | 1.41B | 577.90M | 6.95 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-07-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-22-25 | Initiated | Stephens | Overweight |
| Nov-29-23 | Initiated | Craig Hallum | Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-24-21 | Initiated | BTIG Research | Buy |
| Aug-24-21 | Initiated | Cowen | Outperform |
| Aug-24-21 | Initiated | Stephens | Overweight |
| Aug-24-21 | Initiated | Stifel | Buy |
| Aug-24-21 | Initiated | Wedbush | Outperform |
| Aug-24-21 | Initiated | William Blair | Outperform |
View All
Maxcyte Inc Stock (MXCT) Latest News
MaxCyte Inc. stock daily chart insightsBond Market & Long Hold Capital Preservation Tips - newser.com
Using portfolio simulators with MaxCyte Inc. includedPrice Action & Real-Time Volume Trigger Notifications - newser.com
Can MaxCyte Inc. rally from current levelsJuly 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com
MaxCyte Inc. stock trend forecastPortfolio Profit Report & Free Community Consensus Stock Picks - newser.com
MaxCyte Inc.’s volatility index tracking explainedWeekly Trade Analysis & Weekly High Conviction Ideas - newser.com
Is MaxCyte Inc. showing signs of accumulationTrade Exit Report & Safe Capital Growth Plans - newser.com
Winners Losers: How does MaxCyte Inc. score in quality rankingsJuly 2025 Technicals & Trade Opportunity Analysis Reports - khodrobank.com
Aug Setups: Is MaxCyte Inc. a top pick in the sectorJuly 2025 Levels & Weekly High Potential Stock Alerts - khodrobank.com
Pattern recognition hints at MaxCyte Inc. upsidePortfolio Gains Summary & Risk Managed Investment Entry Signals - newser.com
What to do if you’re stuck in MaxCyte Inc.2025 Price Momentum & Smart Investment Allocation Tips - newser.com
Is MaxCyte Inc. stock reversal real or fakeStop Loss & Proven Capital Preservation Tips - newser.com
Swedbank AB Sells 210,000 Shares of MaxCyte, Inc. $MXCT - MarketBeat
What are MaxCyte Incs recent SEC filings showingJuly 2025 Reactions & Weekly High Return Opportunities - خودرو بانک
Trade Recap: Is MaxCyte Inc stock a value trapDip Buying & High Conviction Trade Alerts - khodrobank.com
Weekly Trades: Can MaxCyte Inc. disrupt its industryPortfolio Value Summary & Advanced Technical Signal Analysis - khodrobank.com
Is MaxCyte Inc. building a consolidation baseTrade Volume Summary & High Win Rate Trade Alerts - newser.com
Is now a turning point for MaxCyte Inc.Trend Reversal & Free Reliable Trade Execution Plans - newser.com
Does MaxCyte Inc. have a sustainable dividendEarnings Recap Report & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Insider Trends: Is MaxCyte Inc a top pick in the sectorMarket Rally & Long-Term Capital Growth Strategies - khodrobank.com
Guidance Update: Will PINS benefit from AI trendsWeekly Market Report & Free Reliable Trade Execution Plans - خودرو بانک
Stock Analysis: Is MaxCyte Inc stock risky to hold nowWall Street Watch & Risk Managed Investment Entry Signals - khodrobank.com
Trend Report: What is the next catalyst for MaxCyte IncJuly 2025 Patterns & High Conviction Investment Ideas - خودرو بانک
Can machine learning forecast MaxCyte Inc. recovery2025 Winners & Losers & Free Community Supported Trade Ideas - newser.com
MaxCyte signs platform license agreement with Adicet Bio - MSN
MaxCyte Inc. stock outlook for YEAR2025 Technical Overview & Real-Time Market Sentiment Alerts - Newser
Is now the right time to enter MaxCyte Inc.Weekly Trend Summary & Stepwise Entry and Exit Trade Signals - Lancaster City Council
Will MaxCyte Inc. rebound enough to break evenTrade Volume Report & AI Powered Buy/Sell Recommendations - Newser
Can MaxCyte Inc. disrupt its industryWeekly Trend Recap & AI Forecasted Entry and Exit Points - beatles.ru
MaxCyte, Inc. (NASDAQ:MXCT) Q4 2024 Earnings Call Transcript - MSN
268,541 Shares in MaxCyte, Inc. $MXCT Purchased by Nuveen LLC - MarketBeat
What is the PEG ratio of MaxCyte Inc.Quarterly Market Summary & Safe Entry Zone Identification - 뉴스영
Historical volatility pattern of MaxCyte Inc. visualizedWeekly Profit Report & Technical Buy Zone Confirmations - Newser
Multi asset correlation models including MaxCyte Inc.Market Growth Report & Weekly High Potential Stock Alerts - Newser
MaxCyte Inc. stock trendline breakdown2025 Risk Factors & Smart Money Movement Alerts - Newser
Why is MaxCyte Inc. stock going downAnalyst Downgrade & Real-Time Price Movement Reports - خودرو بانک
Applying Elliott Wave Theory to MaxCyte Inc.Chart Signals & Reliable Entry Point Alerts - Newser
Momentum divergence signals in MaxCyte Inc. chartCEO Change & Free Community Consensus Stock Picks - Newser
What is the target price for MaxCyte Inc. stock2025 Market Trends & Fast Moving Stock Trade Plans - 뉴스영
Applying chart zones and confluence areas to MaxCyte Inc.2025 Key Lessons & Risk Controlled Stock Alerts - Newser
Can MaxCyte Inc. hit a new high this month2025 Big Picture & Scalable Portfolio Growth Ideas - Newser
How to use Fibonacci retracement on MaxCyte Inc.Trade Risk Assessment & Daily Volume Surge Signals - Newser
How to recover losses in MaxCyte Inc. stockDip Buying & Fast Gain Swing Trade Alerts - Newser
Measuring MaxCyte Inc.’s beta against major indicesPortfolio Profit Report & AI Enhanced Trading Alerts - Newser
How to integrate MaxCyte Inc. into portfolio analysis tools2025 Year in Review & Growth Oriented Trade Recommendations - Newser
What’s the recovery path for long term holders of MaxCyte Inc.July 2025 Breakouts & Free Reliable Trade Execution Plans - Newser
Will MaxCyte Inc. price bounce be sustainableMarket Performance Report & Stock Portfolio Risk Control - Newser
What’s next for MaxCyte Inc. stock priceInsider Buying & Accurate Entry/Exit Alerts - Newser
Signal strength of MaxCyte Inc. stock in tech scannersMarket Growth Report & Community Consensus Picks - Newser
Visual analytics tools that track MaxCyte Inc. performanceInsider Buying & Verified Entry Point Detection - Newser
Should value investors consider MaxCyte Inc.Weekly Volume Report & Reliable Entry Point Trade Alerts - خودرو بانک
Using economic indicators to assess MaxCyte Inc. potential2025 Stock Rankings & Real-Time Chart Pattern Alerts - Newser
Maxcyte Inc Stock (MXCT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Maxcyte Inc Stock (MXCT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Swirsky Douglas J | CHIEF FINANCIAL OFFICER |
Aug 13 '25 |
Buy |
1.29 |
50,000 |
64,500 |
161,811 |
| Masoud Maher | President and CEO |
Aug 13 '25 |
Buy |
1.37 |
75,000 |
102,915 |
175,000 |
| Erck Stanley C | Director |
Aug 13 '25 |
Buy |
1.37 |
100,000 |
137,220 |
398,328 |
| DOUGLAS RICHARD | Director |
Aug 13 '25 |
Buy |
1.39 |
80,000 |
111,040 |
230,577 |
| Brooke William W | Director |
Aug 13 '25 |
Buy |
1.29 |
50,000 |
64,500 |
150,879 |
3.50%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):